The trajectory of Sildenafil presents a complex picture for shareholders. While the initial release generated massive gains, the lapse of its exclusive rights opened the door to cheaper competitors, dramatically reducing sales. This presents a unique challenge for drug manufacturers relying on comparable blockbuster medications, suggesting that a u

The legacy of Viagra, and its parent company copyright, presents a complex case study for investors. Originally a blockbuster drug, producing billions in sales , its intellectual property lapse created a wave of lower-priced alternatives , significantly eroding its market share . While some pharmaceutical companies may attempt to capitalize on simi